Latest filing published 15 Feb 2018 for Vaxart, Inc..
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -35.6%Entry US$60.78 · Close at T+365 US$39.17
- -17.8%Entry US$57.64 · Close at T+365 US$47.40
- +21.2%Entry US$52.38 · Close at T+365 US$63.46
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jan Leschly: trading record in brief
Jan Leschly is a declared insider at 2 companies; the most frequent names are American Express Co and Vaxart, Inc. We count 17 filings; the first trade dates from 28 April 2006 and the latest from 13 February 2018.
The open-market side counts 5 purchases for €5.9M alongside 5 sales for €3.3M. Netting one side against the other leaves €2.6M of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants and 5 option exercises.
A typical purchase (the median) is worth €1.5M. Ninety days after publication, 3 purchases show a median change of -0.5%, with the price up in 33% of them. Past outcomes like these are no guarantee of what comes next.
Most recently, on 15 February 2018, the filings show a share grant in Vaxart, Inc. The clock since the last published purchase (21 November 2012) now reads 5,101 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jan Leschly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,793,670 sharesCommon StockSEC:0001140361-18-008682:0
- 35,250 shares@ US$55.10Common StockSEC:0001127602-12-031910:0
- 35,250 shares@ US$55.08Common StockSEC:0001127602-12-031910:1
- 35,250 shares@ US$55.16Common StockSEC:0001127602-12-031910:2Canonical exit: 17 Feb 2013 (T+90)
- 35,250 shares@ US$55.17Common StockSEC:0001127602-12-031910:3Canonical exit: 17 Feb 2013 (T+90)
- 3,427 shares@ US$37.71Common StockSEC:0001127602-12-009249:0
- 3,427 shares@ US$53.43Common StockSEC:0001127602-12-009249:1
- 3,427 shares@ US$35.57Common StockSEC:0001127602-11-002570:0
- 2,818 shares@ US$44.84Common StockSEC:0001127602-11-002570:1
- 609 shares@ US$44.84Common StockSEC:0001127602-11-002570:2
- 3,427 shares@ US$42.77Common StockSEC:0001127602-10-011979:0
- 3,427 shares@ US$29.91Common StockSEC:0001127602-08-002659:0
- 2,185 shares@ US$46.89Common StockSEC:0001127602-08-002659:1
- 32,000 shares@ US$62.33Common StockSEC:0001127602-07-003260:0Canonical exit: 6 Nov 2007 (T+90)
- 3,427 shares@ US$18.33Common StockSEC:0001127602-07-001150:0
- 16,200 shares@ US$58.49Common StockSEC:0001127602-07-000306:0Canonical exit: 24 Apr 2007 (T+90)
- 15,000 shares@ US$53.93Common StockSEC:0001127602-06-001045:0Canonical exit: 27 Jul 2006 (T+90)
17 of 17 declarations
